License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ...

Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions ...

The reported 2024 results show narrow TREO variance (~0.39–0.54% TREO) with stable ~27% HREO proportion across multiple ...

Bluerock Private Real Estate Fund Announces Share Repurchase Program. NEW YORK, Dec. 16, 2025 /PRNewswire/ -- Bluerock Private Real Estate Fund (BPRE or the Fund), a closed-end fund offering dedicated ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

Since September 30, 2025, a total of 6,271,071 warrants have been exercised for proceeds of C$3.0 million. As at December 15 ...

Zeta Global (NYSE: ZETA), the AI Marketing Cloud, today announced its presence at CES 2026, including an exclusive happy hour and fireside chat at Zeta's Athena suite. Renowned tech analyst, media ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Detailed price information for Cosa Resources Corp. (COSA-X) from The Globe and Mail including charting and trades.

Detailed price information for Caprock Mining Corp (CAPR-CN) from The Globe and Mail including charting and trades.

The next phase of JFK’s Terminal 6 redevelopment adds 24 new artworks and two major murals, extending the terminal’s ...

Cosa Resources is a Canadian uranium exploration company operating in northern Saskatchewan. The portfolio comprises roughly ...